James P. Quinlan's most recent trade in Medicus Pharma Ltd was a trade of 125,000 Common Shares, no par value ("Common Shares") done at an average price of $0.8 . Disclosure was reported to the exchange on Aug. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicus Pharma Ltd | James P. Quinlan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.81 per share. | 13 Aug 2025 | 125,000 | 254,147 | - | 0.8 | 101,250 | Common Shares, no par value ("Common Shares") |
| Medicus Pharma Ltd | James P. Quinlan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 125,000 | 0 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | James P. Quinlan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. | 13 Aug 2025 | 20,000 | 274,147 | - | 2.8 | 55,000 | Common Shares |
| Medicus Pharma Ltd | James P. Quinlan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | James P. Quinlan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |